Author

SN Jenkins

Institutions: Mayo Clinic, University of Chicago, Fred Hutch Cancer Center, West Cancer Center

Observed institutions: Mayo Clinic, University of Chicago, Fred Hutch Cancer Center, West Cancer Center

OpenAlex ID: A5073698331

Abstract OT1-01-02: An open-label, randomized, multi-center phase 2 study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of postmenopausal women with locally advanced or metastatic ER+/HER2 - breast cancer (MBC) with an ESR1 mutation

2019 · PV Plourde, LS Schwartzberg, et al. · Cancer Research · 3

Works count: 1

Citation count: 3

H-index: 1

I10-index: